Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
TransCode Therapeutics, Inc.
Market Cap
$1.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.84M
Operating Margin
-324.34%
TTM Avg
-372.21%
3Y Avg
-997.85%
5Y Avg
-1542.23%
Market Cap
$1.84M
Operating Margin
-378.23%
TTM Avg
-790.15%
3Y Avg
-1754.14%
5Y Avg
-1593.52%
Market Cap
$1.83M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.81M
Operating Margin
-84500.00%
TTM Avg
-66310.00%
3Y Avg
-204790.35%
5Y Avg
-139774.35%
Market Cap
$2.13M
Operating Margin
-869.34%
TTM Avg
-752.59%
3Y Avg
-4678.16%
5Y Avg
-3954.97%
Market Cap
$2.14M
Operating Margin
-107.92%
TTM Avg
-94.19%
3Y Avg
-117.47%
5Y Avg
-112.89%
Market Cap
$1.64M
Operating Margin
-5936.95%
TTM Avg
-6231.69%
3Y Avg
-5710.52%
5Y Avg
-4448.84%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransCode Therapeutics, Inc. (RNAZ) | $1.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | -324.34% | -372.21% | -997.85% | -1542.23% |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | -378.23% | -790.15% | -1754.14% | -1593.52% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -84500.00% | -66310.00% | -204790.35% | -139774.35% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -869.34% | -752.59% | -4678.16% | -3954.97% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | -107.92% | -94.19% | -117.47% | -112.89% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -5936.95% | -6231.69% | -5710.52% | -4448.84% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -102380.23% | -77298.57% | -57151.39% | -38807.57% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
